TOWERVIEW LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.

Quarter-by-quarter ownership
TOWERVIEW LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$158,000
-61.9%
25,000
-50.0%
0.08%
-58.3%
Q1 2022$415,000
-40.8%
50,000
-63.0%
0.20%
-41.2%
Q4 2021$701,000
-22.3%
135,0000.0%0.35%
-26.9%
Q3 2021$902,000
-21.6%
135,0000.0%0.48%
-31.5%
Q2 2021$1,150,000
-7.2%
135,000
-3.6%
0.69%
-10.0%
Q1 2021$1,239,000
-22.5%
140,000
+7.7%
0.77%
-32.5%
Q4 2020$1,598,000
+63.6%
130,000
+8.3%
1.14%
+52.1%
Q3 2020$977,000
+31.3%
120,000
+54.8%
0.75%
+30.7%
Q2 2020$744,00077,5000.57%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders